Sign in | About Us | Contact Us

Product CAS# Supplier

Sign in | Join free | Shopping Online | Product Index | Buy,Sell (New)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

0

1

2

3

4

5

6

7

8

9

Phase I-II Trial of Bortezomib Plus Oral Cyclophosphamide and Prednisone in Relapsed and Refractory Multiple Myeloma        Cipla eyeing copies of 20 patented drugs        Cyclacel Publishes Study of Seliciclib Synergy with Tarceva(Erlotinib) and Herceptin in Journal Clinical Cancer Research        FDA MedWatch- Avastin (bevacizumab) and Sunitinib Malate- Reports of Microangiopathic Hemolytic Anemia In Patients Treated With This Combination        最近美国临床药理和治疗学协会一个研究表明在进食中服用拉帕替尼(Lapatinib)能节省药物费用        Infinity Pharmaceuticals Named as One of the Best Places to Work        Indian Patent office to hear drug firms` views before granting licence (Erlotinib, Sunitinib)        Study of Lonafarnib Versus Placebo        Cediranib (AZD2171, RECENTIN?) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer        Pharmaceutical facility news in brief        Sinclair and Wockhardt strike deal        ProGen launches PharmaSynth manufacturing unit        Heart failure linked to Sutent (Sunitinib) treatment        Noninvasive Monitoring of Tumors        sunitinib (Sutent): New treatment option for patients with liver cancer        Erlotinib & Gefitinib: Promising New Tool to Monitor Lung Cancer Treatment Progress        关于治理化工类企业非法生产经营蛋白同化制剂、肽类激素的公告        Brazil building a future in pharma        Bortezomib, a specific and selective inhibitor of the 26S proteasome with antitumor activity against a wide range of malignancies        众志成城 协力救灾 为地震灾区朋友送上祝福与希望        Jubilant to buy Draxis in $255m deal        Indian firm takes over German biologics plant        Generic drag cant hold back Siegfried's API momentum        FDA makes progress in plans for China presence        Gilead patent case to help Indian firms        En Mйxico se usan anabуlicos en forma legal en el 70% del ganado        Synta Pharmaceuticals Initiates Second Phase 1 Clinical Trial of STA-9090, A Novel Hsp90 Inhibitor        Cancer drug puts licence, patent rules to test        Scrip Yearbook 2008 Charts the Progress of the Pharmaceutical        AZT, 3TC and efavirenz: a tolerable first-line regimen for South African men

苏ICP备05037505号

Copyright 2007 © ChemLink & ChemicalInfo & Pharm-ChemNet . All rights reserved.